Allurion

At Allurion Technologies, Inc., we are at the forefront of a global movement to end obesity, pioneering a revolutionary full-stack weight-loss platform. Through groundbreaking technological innovation, we developed the Allurion Program, a comprehensive solution that redefines the approach to weight management. Central to our innovation is the Allurion Gastric Balloon, the world's first and only swallowable, procedure-less gastric balloon. This non-invasive marvel is administered in a brief outpatient visit, eliminating the need for surgery, endoscopy, or anesthesia, thus making effective weight loss more accessible and convenient for individuals worldwide. Our commitment to technological advancement extends beyond the balloon itself, as we integrate cutting-edge digital capabilities to support patients throughout their journey.

The Allurion Program is further enhanced by our sophisticated Allurion Virtual Care Suite (VCS). This digital ecosystem features AI-powered remote patient monitoring tools, including the Allurion Mobile App, Allurion Insights for clinicians leveraging the Iris AI Platform, and connected devices like the Allurion Connected Scale and Health Tracker. These innovations provide real-time data and personalized insights, empowering both patients and healthcare providers to customize, monitor, and manage weight loss therapy effectively. Our proprietary behavior change program, embedded within the VCS, offers a library of resources in multiple languages, addressing diet, nutrition, mental wellness, sleep, and goal setting. By combining our novel medical device technology with advanced AI and a holistic behavior change program, Allurion is not just treating obesity; we are revolutionizing how the world approaches long-term weight management and fostering healthier lifestyles on a global scale. We are dedicated to continuous research and development, striving to enhance our offerings and expand our reach to combat one of the world's most pressing health challenges.